Source:http://linkedlifedata.com/resource/pubmed/id/15566856
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2004-11-29
|
| pubmed:abstractText |
We have investigated the performance of the novel rubella serology assay, Cobas Core Rubella IgG EIA recomb, which uses rubella-like particles (RLPs) expressed in transfected BHK-21 cells as the antigen.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0928-0197
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
5
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
13-20
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Evaluation of recombinant rubella-like particles in a commercial immunoassay for the detection of anti-rubella IgG.
|
| pubmed:affiliation |
Institute of Medical Microbiology, University of Leipzig, Liebigstrasse 24, D-04103 Leipzig, Germany.
|
| pubmed:publicationType |
Journal Article
|